Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

Weight Loss Drug’s Ozempic Counterfeit: Rising Reports Over Patient Safety Related Fake Drugs

By Vandana Singh
January 24, 3:21 PM
Discover the alarming rise in fake Ozempic cases, leading to hypoglycemia. Learn about FDA investigations, counterfeit warnings, and the surge in reports.

LLY

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News

Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today?

By Vandana Singh
January 24, 3:08 PM
Evaxion Biotech revolutionizes cancer vaccine development, targeting AI-identified ERVs. Preclinical activities underway; Proof-of-Concept data expected by 2H 2024.

EVAX

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News

Heron Therapeutics’ Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures – FDA Gives Nod

By Vandana Singh
January 24, 12:47 PM
Zynrelef's expanded FDA approval for soft tissue and orthopedic surgeries, offering superior pain management with lower pain scores and opioid consumption.

HRTX

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • Movers
  • News
  • Offerings
  • Trading Ideas

Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?

By Vandana Singh
January 24, 12:16 PM
Latest surge in Kura Oncology shares with a $150 million private placement announcement. Cash runway extended into 2027.

KURA

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

Gilead’s Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of “Risks Of Secondary Cancer’

By Vandana Singh
January 24, 11:36 AM
FDA issues classwide black box warning for CAR-T therapies due to T-cell cancer risk. Drops Gilead's cell therapy from the list.

BMY

Read More
3 minute read
  • Biotech
  • Economics
  • General
  • Macro Economic Events
  • News

“American Medical Association Says Safe Drug Consumption Sites ‘Save Lives’ By Reducing Risky Behaviors And Overdose Deaths” – Marijuana Moment

By Benzinga Newsdesk
January 24, 10:43 AM
https://www.marijuanamoment.net/american-medical-association-says-safe-drug-consumption-sites-save-lives-by-reducing-risky-behaviors-and-overdose-deaths/In a little-noticed section of a report on the nation's worsening

ACB

Read More
2 minute read
  • Biotech
  • General
  • News

LANGaware Forges Transformative Collaboration With Premier, Inc.’s PINC AI Applied Sciences To Revolutionize Healthcare

By Benzinga Newsdesk
January 24, 10:16 AM
Real-world data to support early patient identification for patients with neurodegenerative and behavioral health diseases.NEW YORK, Jan. 24, 2024 /PRNewswire/ -- LANGaware, an innovative leader in digital cognitive and

PINC

Read More
1 minute read
  • Biotech
  • General
  • News
  • Penny Stocks

Silo Pharma Announces Results In Alzheimer’s Disease Study; Preclinical Study Shows SPC-14’s Effectiveness Against LH Stress, Helplessness, And Anxiety

By Benzinga Newsdesk
January 24, 9:55 AM
Preclinical study shows SPC-14's effectiveness against LH (luteinizing hormone) stress, helplessness, and anxiety.    

SILO

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

UroGen Initiates Submission Of A Rolling NDA To The FDA For UGN-102

By Benzinga Newsdesk
January 24, 9:18 AM
UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced the submission of the Chemistry, Manufacturing,

URGN

Read More
2 minute read
  • Biotech
  • General
  • News

Stevanato Group Launches EZ-Fill Kit And Laboratory Fill And Finish Service To Support Small Batch Drug Development And Commercialization

By Benzinga Newsdesk
January 24, 9:17 AM
New developments in the biopharmaceutical field fuel a need for highly scalable and flexible solutionsStevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment and delivery solutions to the

STVN

Posts pagination

Previous 1 … 116 117 118 … 795 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service